Plozalizumab - CAS:1610761-46-0

您当前的位置：

Plozalizumab

目录号 : KM38502 CAS No. : 1610761-46-0 纯度 : 95%

Data Sheet 产品使用指南

Plozalizumab (MLN-1202) 是一种人源化抗 CCR2 IgG1 单克隆抗体。Plozalizumab 通过抑制 CCL2/CCR2 轴阻断髓系细胞向肿瘤微环境的招募。此外，Plozalizumab 也可改善类风湿性关节炎中的滑膜炎症。Plozalizumab 可用于恶性黑色素瘤和骨转移相关癌症的研究。推荐同型对照: Human IgG1 kappa, Isotype Control 。

规格	价格	是否有货
1mg		In-stock
5mg	询价	In-stock
10mg	询价	In-stock
50mg	询价	In-stock

加入购物车大包装询价

Other Forms of Rapamycin:

Runimotamab In-stock
CCPA hemihydrate In-stock
Rapaprutug In-stock
Levulinic acid-d5 In-stock
D-Arabitol-d7 In-stock

KKL Med 的所有产品和服务仅用于科学研究，不能被用于人体，兽医，我们也不向个人提供产品和服务。

生物活性	Plozalizumab (MLN-1202) is a humanized anti-CCR2 IgG1 monoclonal antibody. Plozalizumab blocks the recruitment of myeloid cells to the tumor microenvironment by inhibiting the CCL2/CCR2 axis. In addition, Plozalizumab can also improve synovial inflammation in rheumatoid arthritis. Plozalizumab can be used in the research of malignant melanoma and bone metastasis-related cancers. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control .
分子量	146.08 kDa
CAS号	1610761-46-0
中文名称	Plozalizumab
运输条件	Shipping with dry ice.
储存方式	Store at -20˚C